Dr. Aravind Mani, MD

Dr. Mani practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Mani's NPI, 1932151941, was assigned on May 17, 2006. Dr. Mani graduated from Stanford University School Of Medicine in 2003. Dr. Mani holds California license A92145.

Dr. Mani's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Mani's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Mani is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Pacific Inpatient Medical Group. Dmand AI also links Dr. Mani to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mani practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mani's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mani is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mani is licensed in California.

Dmand AI lists cardiac arrhythmia, chronic kidney disease, congestive heart failure, electrolyte disorders, heart failure, hypertension, kidney failure and pneumonia and respiratory infection among the conditions Dr. Mani treats.

CMS data shows 384 Medicare services from Dr. Mani across 6 procedure codes in 2024, for 203 Medicare patients. Medicare paid $34,606 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 203 Medicare patients who saw Dr. Mani in 2024. The largest group is 75 to 84, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mani's median patient age at 73, with 50% women.

In 2024, Dr. Mani wrote 96 Medicare Part D claims for 50 patients. 74% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $4,451 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mani for performance year 2024, reported as part of a group. Dr. Mani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Mani in 2021. The most frequent topics are COVID-19 and Electronic Health Records. Dr. Mani's most frequent co-authors are Noha Mandouh Aboelata, MD, Christopher Frederick Beaulieu, MD and Robert Brooke Jeffrey, MD.

CMS Open Payments shows 1 general payment to Dr. Mani from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $23.

Dr. Mani graduated from Stanford University School Of Medicine in 2003. Dr. Mani is a member of SHM.

Dr. Mani is in network with 6 carriers, including United Healthcare, Aspirus Health Plan and Blue Cross and Blue Shield of Kansas City. PPO plans come from the most carriers, 3. Check the plan with the practice before a visit.